Answer
Women of reproductive potential should use effective contraception during Lutathera (lutetium (177Lu) oxodotreotide) treatment and for 7 months after their last dose.
Sources for this answer
- Lutathera 370 MBq/mL solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked